Literature DB >> 24308836

Understanding the role of B cells in atherosclerosis: potential clinical implications.

Samuel Morris-Rosenfeld1, Michael J Lipinski, Coleen A McNamara.   

Abstract

Atherosclerosis is a progressive inflammatory disease of the medium to large arteries that is the largest contributor to cardiovascular disease. B-cell subsets have been shown in animal models of atherosclerosis to have both atherogenic and atheroprotective properties. In this review, we highlight the research that developed our understanding of the role of B cells in atherosclerosis both in humans and mice. From this we discuss the potential clinical impact B cells could have both as diagnostic biomarkers and as targets for immunotherapy. Finally, we recognize the inherent difficulty in translating findings from animal models into humans given the differences in both cardiovascular disease and the immune system between mice and humans, making the case for greater efforts at addressing the role of B cells in human atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308836      PMCID: PMC4358742          DOI: 10.1586/1744666X.2014.857602

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  115 in total

Review 1.  Natural IgM antibodies against oxidation-specific epitopes.

Authors:  Christoph J Binder
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 2.  Atherosclerotic lesions in mouse and man: is it the same disease?

Authors:  Jacob Fog Bentzon; Erling Falk
Journal:  Curr Opin Lipidol       Date:  2010-10       Impact factor: 4.776

Review 3.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

4.  Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection.

Authors:  C A Pennell; T J Mercolino; T A Grdina; L W Arnold; G Haughton; S H Clarke
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

5.  Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice.

Authors:  X Zhou; G K Hansson
Journal:  Scand J Immunol       Date:  1999-07       Impact factor: 3.487

Review 6.  Established risk factors and coronary artery disease: the Framingham Study.

Authors:  P W Wilson
Journal:  Am J Hypertens       Date:  1994-07       Impact factor: 2.689

7.  Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention.

Authors:  Michael J Lipinski; Robert E Martin; Michael J Cowley; Evelyne Goudreau; Walter N Malloy; Robert E Johnson; George W Vetrovec
Journal:  Clin Cardiol       Date:  2006-01       Impact factor: 2.882

8.  HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab.

Authors:  Hennie G Raterman; Han Levels; Alexandre E Voskuyl; Willem F Lems; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2012-05-15       Impact factor: 19.103

9.  Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.

Authors:  Elena Galkina; Alexandra Kadl; John Sanders; Danielle Varughese; Ian J Sarembock; Klaus Ley
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

10.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline.

Authors:  T J Mercolino; A L Locke; A Afshari; D Sasser; W W Travis; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  B cells and atherosclerosis.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

2.  The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway.

Authors:  Xianyao Li; Yaqin Tang; Binbin Ma; Zheng Wang; Jinying Jiang; Shengjie Hou; Shuhang Wang; Jie Zhang; Meichun Deng; Zhigui Duan; Xing Tang; Alex F Chen; Liping Jiang
Journal:  Inflamm Res       Date:  2018-03-10       Impact factor: 4.575

3.  B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.

Authors:  Sam M Rosenfeld; Heather M Perry; Ayelet Gonen; Thomas A Prohaska; Prasad Srikakulapu; Sukhdeep Grewal; Deepanjana Das; Chantel McSkimming; Angela M Taylor; Sotirios Tsimikas; Timothy P Bender; Joseph L Witztum; Coleen A McNamara
Journal:  Circ Res       Date:  2015-06-16       Impact factor: 17.367

Review 4.  Fibroblast growth factor-transforming growth factor beta dialogues, endothelial cell to mesenchymal transition, and atherosclerosis.

Authors:  Pei-Yu Chen; Michael Simons
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

5.  A functionally significant polymorphism in ID3 is associated with human coronary pathology.

Authors:  Ani Manichaikul; Stephen S Rich; Heather Perry; Joseph Yeboah; Michelle Law; Molly Davis; Matthew Parker; Michael Ragosta; Jessica J Connelly; Coleen A McNamara; Angela M Taylor
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

6.  IgE, α-Gal and atherosclerosis.

Authors:  Jeffrey M Wilson; Coleen A McNamara; Thomas A E Platts-Mills
Journal:  Aging (Albany NY)       Date:  2019-04-05       Impact factor: 5.682

Review 7.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022

Review 8.  B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications.

Authors:  Tanyaporn Pattarabanjird; Cynthia Li; Coleen McNamara
Journal:  JACC Basic Transl Sci       Date:  2021-06-28

Review 9.  Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged.

Authors:  Thomas L Rothstein
Journal:  Front Immunol       Date:  2016-04-07       Impact factor: 7.561

10.  Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study.

Authors:  Anoop Dinesh Shah; Spiros Denaxas; Owen Nicholas; Aroon D Hingorani; Harry Hemingway
Journal:  Open Heart       Date:  2016-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.